Search - tctmd.com

Displaying 21 - 40 of 323

Sort: Relevancy | Date

News Conference News ESC 2024

RESHAPE-HF2 Is a Win for MitraClip in FMR—Not Everyone’s On Board

Shelley Wood

August 31, 2024

News Daily News

ACC/AHA Update Performance, Quality Measures for HF Care

Todd Neale

August 08, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2024

Shelley Wood

July 31, 2024

News Daily News

Make Way, at Last, for the Third MitraClip RCT in Functional MR: RESHAPE-HF 2

Shelley Wood

July 09, 2024

News Conference News NY Valves 2024

Transcatheter Edge-to-Edge Repair Shows Benefit in Moderate MR

Michael O'Riordan

June 10, 2024

News Conference News NY Valves 2024

T-TEER for Tricuspid Regurgitation Induces Reverse Remodeling, Works in Tricky Anatomies

Todd Neale

June 07, 2024

Presentation NY Valves 2024

Long-Term Follow Up With the DUO Coaptation Valve System for the Percutaneous Treatment of Tricuspid Regurgitation: The TANDEM I Trial

Presenter: Wojtek Wojakowski

June 06, 2024

Presentation NY Valves 2024

PRO: M-TEER for COAPT-Eligible Patients Only – The Evidence is Clear

Presenter: JoAnn Lindenfeld

June 06, 2024

Presentation NY Valves 2024

Transcatheter Edge-to-Edge Approach to Repair Large Coaptation Gaps: The Zipping Technique

Presenter: Giulia Passaniti

June 05, 2024

Presentation NY Valves 2024

Phenotypic Diversity in Secondary Mitral Regurgitation: Differential Outcomes Following Transcatheter Edge-to-Edge Repair - Insights From the COAPT and MITRA-FR Trials

Presenter: Guillaume Bonnet

June 05, 2024

News Daily News

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

Michael O'Riordan

May 07, 2024

News Conference News ACC 2024

Early Empagliflozin Doesn’t Curb HF Hospitalizations, Deaths Post-MI: EMPACT-MI

Shelley Wood

April 06, 2024

News Opinion Off Script

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Sanjay Kaul, MD

March 29, 2024

News Daily News

First-Ever Performance, Quality Metrics Created for Valvular and Structural Disease

Michael O'Riordan

March 20, 2024

Presentation THT Abstracts 2024

Association Between Frailty and Outcomes of Transcatheter Edge-to-Edge Repair in Functional Mitral Regurgitation: Results from the COAPT trial

Presenter: Charles Sherrod

March 04, 2024

Presentation Miami Valves 2024

Testing the Limits of TEER Beyond COAPT

Presenter: Diego H. González-Bravo

February 03, 2024

Presentation Miami Valves 2024

Edge to Edge Repair in Severe LV Dilatation (Beyond COAPT)

Presenter: Solomon A. Seifu

February 03, 2024

News Daily News

Lower Mortality With M-TEER vs Surgery, but Devil Is in the Details

Michael O'Riordan

January 25, 2024

News Conference News PCR London Valves 2023

EuroSMR Score Outperforms Other Tools for M-TEER Risk Profiling

Shelley Wood

November 28, 2023

News Conference News PCR London Valves 2023

For the Ideal Tricuspid TEER Patient—Look Beyond TRILUMINATE

Shelley Wood

November 20, 2023

Advertisement

RESHAPE-HF2 Is a Win for MitraClip in FMR—Not Everyone’s On Board

ACC/AHA Update Performance, Quality Measures for HF Care

TCTMD’s Top 10 Most Popular Stories for July 2024

Make Way, at Last, for the Third MitraClip RCT in Functional MR: RESHAPE-HF 2

Transcatheter Edge-to-Edge Repair Shows Benefit in Moderate MR

T-TEER for Tricuspid Regurgitation Induces Reverse Remodeling, Works in Tricky Anatomies

Long-Term Follow Up With the DUO Coaptation Valve System for the Percutaneous Treatment of Tricuspid Regurgitation: The TANDEM I Trial

PRO: M-TEER for COAPT-Eligible Patients Only – The Evidence is Clear

Transcatheter Edge-to-Edge Approach to Repair Large Coaptation Gaps: The Zipping Technique

Phenotypic Diversity in Secondary Mitral Regurgitation: Differential Outcomes Following Transcatheter Edge-to-Edge Repair - Insights From the COAPT and MITRA-FR Trials

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

Early Empagliflozin Doesn’t Curb HF Hospitalizations, Deaths Post-MI: EMPACT-MI

Evoque and Patisiran: A Tale of Two Regulatory Journeys

First-Ever Performance, Quality Metrics Created for Valvular and Structural Disease

Association Between Frailty and Outcomes of Transcatheter Edge-to-Edge Repair in Functional Mitral Regurgitation: Results from the COAPT trial

Testing the Limits of TEER Beyond COAPT

Edge to Edge Repair in Severe LV Dilatation (Beyond COAPT)

Lower Mortality With M-TEER vs Surgery, but Devil Is in the Details

EuroSMR Score Outperforms Other Tools for M-TEER Risk Profiling

For the Ideal Tricuspid TEER Patient—Look Beyond TRILUMINATE

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content